Electromed (ELMD) Revenue Growth (1y) (2011 - 2026)
Electromed (ELMD) Revenue Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 13.02% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 9.42% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 9.86% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 7.53% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 13.63% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 13.08% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 5.75% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 95.64% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 7.30% |
| 10 | Electromed | 327.63 Mn | 310.64 Mn | 14.64 Mn | 18.43% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.43% |
| Dec 31, 2025 | 16.25% |
| Sep 30, 2025 | 15.13% |
| Jun 30, 2025 | 17.27% |
| Mar 31, 2025 | 13.07% |
| Dec 31, 2024 | 18.74% |
| Sep 30, 2024 | 19.02% |
| Jun 30, 2024 | 8.96% |
| Mar 31, 2024 | 14.94% |
| Dec 31, 2023 | 16.71% |
| Sep 30, 2023 | 15.63% |
| Jun 30, 2023 | 20.79% |
| Mar 31, 2023 | 19.00% |
| Dec 31, 2022 | 14.45% |
| Sep 30, 2022 | 6.57% |
| Jun 30, 2022 | 19.01% |
| Mar 31, 2022 | 15.41% |
| Dec 31, 2021 | 7.92% |
| Sep 30, 2021 | 24.95% |
| Jun 30, 2021 | 37.68% |